Literature DB >> 21118396

Alcohol consumption appears to protect against non-alcoholic fatty liver disease.

A Moriya1, Y Iwasaki, S Ohguchi, E Kayashima, T Mitsumune, H Taniguchi, F Ikeda, Y Shiratori, K Yamamoto.   

Abstract

BACKGROUND: Moderate alcohol consumption may have certain beneficial effects against non-alcoholic fatty liver disease, which is associated with metabolic syndrome. AIM: To determine the association between drinking pattern and fatty liver in Japanese men and women.
METHODS: A cross-sectional study was performed with health checkup data including information concerning alcohol consumption and ultrasonographic assessment of fatty liver.
RESULTS: We analysed 4957 men and 2155 women without reported liver diseases (median age, 49 years). In men, 40% of nondrinkers and 28% of drinkers had fatty liver. Alcohol consumption was inversely associated with fatty liver (adjusted odds ratio, 0.54; 95% confidence interval, 0.46-0.63). The prevalence of fatty liver in each category of drinking frequency was 38% (1-3 days/week), 29% (4-6 days/week), and 24% (daily drinking); there was a significant inverse correlation between drinking frequency and the prevalence of fatty liver (P < 0.001). In women, 16% of nondrinkers and 10% of drinkers had fatty liver. Drinking less than 20 g on 1-3 days/week was associated with low prevalence of fatty liver (adjusted odds ratio, 0.47; 95% confidence interval, 0.23-0.96).
CONCLUSIONS: Alcohol consumption appears to protect against non-alcoholic fatty liver disease.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21118396     DOI: 10.1111/j.1365-2036.2010.04520.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  29 in total

1.  Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice.

Authors:  Giridhar Kanuri; Marianne Landmann; Josephine Priebs; Astrid Spruss; Marina Löscher; Doreen Ziegenhardt; Carolin Röhl; Christian Degen; Ina Bergheim
Journal:  Eur J Nutr       Date:  2015-05-24       Impact factor: 5.614

Review 2.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  What should we recommend to our patients with NAFLD regarding alcohol use?

Authors:  Suthat Liangpunsakul; Naga Chalasani
Journal:  Am J Gastroenterol       Date:  2012-07       Impact factor: 10.864

4.  Roles of alcohol drinking pattern in fatty liver in Japanese women.

Authors:  Akio Moriya; Yoshiaki Iwasaki; Souhei Ohguchi; Eizo Kayashima; Tadahiko Mitsumune; Fusao Ikeda; Masaharu Ando; Kazuhide Yamamoto
Journal:  Hepatol Int       Date:  2013-07-17       Impact factor: 6.047

Review 5.  Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD).

Authors:  Helmut K Seitz; Sebastian Mueller; Claus Hellerbrand; Suthat Liangpunsakul
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

6.  Liver and diabetes. A vicious circle.

Authors:  Paola Loria; Amedeo Lonardo; Frank Anania
Journal:  Hepatol Res       Date:  2013-01       Impact factor: 4.288

7.  Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women.

Authors:  Sylvia H Ley; Qi Sun; Monik C Jimenez; Kathryn M Rexrode; Joann E Manson; Majken K Jensen; Eric B Rimm; Frank B Hu
Journal:  Diabetologia       Date:  2013-10-09       Impact factor: 10.122

8.  Hepatic steatosis and steatohepatitis: Are they really two distinct entities?

Authors:  Cory M Fielding; Paul Angulo
Journal:  Curr Hepatol Rep       Date:  2014-06-01

9.  Moderate alcohol intake induces thermogenic brown/beige adipocyte formation via elevating retinoic acid signaling.

Authors:  Bo Wang; Zhixiu Wang; Jeanene M de Avila; Mei-Jun Zhu; Faya Zhang; Noe Alberto Gomez; Liang Zhao; Qiyu Tian; Junxing Zhao; Joseph Maricelli; Hui Zhang; Buel D Rodgers; Min Du
Journal:  FASEB J       Date:  2017-07-05       Impact factor: 5.191

10.  Alcohol consumption in patients with primary sclerosing cholangitis.

Authors:  Hannes Hagström; Per Stål; Knut Stokkeland; Annika Bergquist
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.